The Heart Failure Society of America (HFSA) is committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24-months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity.
Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interests have been resolved in accordance with the ACCME Updated Standards for Commercial Support.
The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest:
- Shauna Wheeler, MSL (CE Review)
The following faculty and/or accreditors with ability to control content for this activity have listed the below disclosures:
- Barry Borlaug - Consultant: Aria, Boehringer Ingelheim, BridgeBio Pharmacy, INC, Edwards LifeSciences, Eli Lilly, Janssen, Merck, Merck, NGMBio, Novo Nordisk, ShouTi, VADovations, Amgen (Ended); Research Support: AstraZeneca, Axon, Corvia Medical, DoD, Medtronic, NIH/NHLBI, Novo Nordisk, Rivus Pharmaceuticals, Tenax Therapeutics, GlaxoSmithKline (Ended), Mesoblast (Ended)
- Zachary Cox - Consultant: Kestra Medical Technologies, Reprieve Cardiovascular, Roche, Vectorious, WhiteSwell, ABIOMED (Ended), Lexicon Pharmaceuticals (Ended); Research Support: Translational Catalyst, AstraZeneca (Ended), Cumberland Pharmaceuticals (Ended)
- Carolyn Lam - Alnylam Pharmaceuticals, AnaCardio, Applied Therapeutics, AstraZeneca, Bayer AG, Boehringer Ingelheim, Boston Scientific, BridgeBio Pharma, Corteria, CPC Clinical Research, Cytokinetics, Eli Lily, EvlaBio AG, ICON Clinical Research, Impulse Dynamics, Intellia Therapeutics, Janssen, Klyv Therapeutics, Medscape/WebMD, Global, Merck, Novartis, Novo Nordisk, Pfizer, Radcliffe Group Ltd, Ribocure Pharmaceuticals, Roche, Tenax Therapeutics, Us2.ai; Co-Founder: Us2.ai; Research Support: Novo Nordisk, Roche
- Kavita Sharma - Advisory Panel: Alleviant Medical, Bristol-Myers Squibb, Novartis, RIVUS, Janssen (Ended); Consultant: AstraZeneca, Bayer AG, Edgewise Therapeutics, Edwards LifeSciences, Imbria, Novartis, Novo Nordisk; Research Support: Amgen
Off-Label Disclosure
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.